載入中
NASDAQHealthcareDrug Manufacturers - Specialty & Generic
最新資料
US$0.1487
−US$0.1948 · -56.71%
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.
前收盤價
US$0.1487
−US$0.1948 · -56.71%
盤中時間採用ET。市場資料可能有所延遲。
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.
日內區間
目前US$0.1487
52週區間
目前US$0.1487
盤中時間採用ET。市場資料可能有所延遲。
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.
日內區間
目前US$0.1487
52週區間
目前US$0.1487
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（USD） | 2026會計年度 | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 |
|---|---|---|---|---|---|
| 營收 | 107.26萬 USD | 174.09萬 USD | 192.85萬 USD | 197.17萬 USD | 260.23萬 USD |
| 銷貨成本 | 88.94萬 USD | 137.35萬 USD | 137.45萬 USD | 154.54萬 USD | 135.06萬 USD |
| 毛利 | 18.33萬 USD | 36.74萬 USD | 55.4萬 USD | 42.63萬 USD | 125.16萬 USD |
| 研究與開發 | 17.88萬 USD | 19.14萬 USD | 18.42萬 USD | — | — |
| 銷售、一般及管理費用 | 712.75萬 USD | 304.79萬 USD | 306.92萬 USD | 603.38萬 USD | 644.13萬 USD |
| 營業費用 | 730.62萬 USD | 304.79萬 USD | 306.92萬 USD | 603.38萬 USD | 644.13萬 USD |
| 利息支出 | 6.3萬 USD | 64.82萬 USD | 54.43萬 USD | 47.68萬 USD | 3.67萬 USD |
| 折舊和攤銷 | 14.32萬 USD | 8.23萬 USD | 20.32萬 USD | 25.02萬 USD | 32萬 USD |
| 營業利益 | −712.29萬 USD | −268.05萬 USD | −251.52萬 USD | −560.75萬 USD | −518.97萬 USD |
| 淨利 | −620.51萬 USD | −330.37萬 USD | −309.85萬 USD | −593.48萬 USD | −573.61萬 USD |
公司資料更新於 2026年10月11日。
近期已公布業績
近期已公布業績
| 行動 | 生效日期 | 詳情 | 記錄日期 | 付款日期 |
|---|---|---|---|---|
股票分割 | 2026年8月10日 | 1:80 | — | — |
股票分割 | 2026年2月3日 | 1:150 | — | — |
股票分割 | 2025年2月25日 | 1:8 | — | — |
股票分割 | 2023年10月5日 | 1:25 | — | — |
股票分割 | 2022年5月19日 | 1:20 | — | — |
股票分割 | 2021年2月22日 | 1:4 | — | — |
已生效 2026年8月10日
1:80
已生效 2026年2月3日
1:150
已生效 2025年2月25日
1:8
已生效 2023年10月5日
1:25
已生效 2022年5月19日
1:20
已生效 2021年2月22日
1:4
AI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
